Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Accuray GAAP EPS of $0.03 In-line, Revenue of $134.3M Beats by $12.79M
Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability'
Genprex Stock Slides 14% Following Reqorsa Study Updates
Gilead Wins FDA Nod for Liver Disease Drug
Puma Biotechnology Quickly Drops After Patents for Tagrisso Ruled Invalid
In-Depth Analysis: Merck & Co Versus Competitors In Pharmaceuticals Industry
Here's the Major Earnings After the Close Today
Accuray Q4 2024 Earnings Preview
Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
What's Going On With Pfizer Shares Tuesday?
9 Health Care Stocks Whale Activity In Today's Session
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
Pfizer Options Trading: A Deep Dive Into Market Sentiment
Judge Rules Against Novartis' Effort To Halt Generic Launch Of Its Top-Selling Heart Disease Drug
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
Maravai Cut at Morgan Stanley; Pfizer/BioNTech Headwinds Cited
China's pharmaceutical companies have once again created a major drug. | Insight Research
Is there a trend of TCE dual resistance?
Fed Court Rules Against Novartis in Generic Entresto Case: Report
Pfizer Trades in the Red for Seven Straight Days
Market Whales and Their Recent Bets on PFE Options